This is a StreetInsider.com Premium Only Page

Epizyme (EPZM) – Analyst EPS View

Mar 13, 2018 01:21 PM Epizyme (EPZM) PT Lowered to $25 at Oppenheimer on 4Q Report; 'Provides Encouraging Clinical Update'

Mar 10, 2017 08:35 AM Epizyme (EPZM) PT Lowered to $19 at RBC Capital on Tazemetostat Questions, Mgmt Departures

Mar 14, 2016 07:34 AM

Nov 9, 2015 12:43 PM

Jul 6, 2015 09:07 AM

Jul 15, 2014 07:24 AM

Jun 26, 2013 04:49 PM